ArticleFrontiers in oncology2022

Fulvestrant May Falsely Increase 17β-Estradiol Levels in Immunoassays: A Case Report of a 57-Year-Old Postmenopausal Patient With Recurrent Estrogen Receptor-Positive Breast Cancer.

Jingxian Ding et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.